CN111529634A - Qingyeyupingfeng powder medicine beverage and preparation method thereof - Google Patents
Qingyeyupingfeng powder medicine beverage and preparation method thereof Download PDFInfo
- Publication number
- CN111529634A CN111529634A CN202010504711.8A CN202010504711A CN111529634A CN 111529634 A CN111529634 A CN 111529634A CN 202010504711 A CN202010504711 A CN 202010504711A CN 111529634 A CN111529634 A CN 111529634A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- root
- chinese medicine
- qingyeyupingfeng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Abstract
The invention discloses a Qingyeyupingfeng powder medicinal beverage and a preparation method thereof, wherein the Qingyeyupingfeng powder medicinal beverage comprises the following raw materials in parts by weight: 12-17 parts of astragalus membranaceus, 9-12 parts of bighead atractylodes rhizome, 8-12 parts of radix sileris, 13-16 parts of folium isatidis, 7-12 parts of scutellaria baicalensis, 8-13 parts of platycodon grandiflorum, 9-13 parts of radix scrophulariae, 8-11 parts of radix ophiopogonis, 13-17 parts of rhizoma phragmitis, 9-12 parts of mint, 8-12 parts of wrinkled gianthyssop herb, 8-12 parts of pericarpium citri reticulatae and 9-12 parts of liquorice. The Qingyeyupingfeng powder medicine drink is a prescription for strengthening healthy energy, improving immunity, clearing away the lung-heat and detoxifying, strengthening the spleen and regulating qi and defending evil, and is suitable for all people. The medicinal beverage has clear overall thought, comprehensive consideration, strict formula, golden drug use and mild drug property, and can be used for preventing, treating and recovering, reducing the damage of chemical articles to viscera and lightening sequelae.
Description
Technical Field
The invention relates to the technical field of medicinal drinks, in particular to a Qingye Yupingfeng powder medicinal drink and a preparation method thereof.
Background
The novel coronavirus pneumonia, called new coronavirus pneumonia for short, and called NCP for short, is infected by coronavirus COVID-19 to cause disease, and is an infectious disease which is the name of modern medicine. In Su Wen & Ci Fang Lun of Huang Di Nei, it is stated that all of the five epidemic diseases are easily infected, and have similar symptoms. "avoid poison gas and take the place of pregnancy. What are natural mares? It is the nose, and the epidemic febrile disease is explained specially in Wen Yi Lun (treatise on epidemic febrile diseases) of Wu Ke Ming Dynasty. He says that "pestilence qi is also involved in the heaven and" pestilence qi comes from the epidemic qi, and the disease is caused by the contact of the pestilence qi with the pestilence qi. Epidemic diseases is the qi of pestilential diseases in nature. The disease is known to be an epidemic disease, which is an infection, and the disease is the same disease state no matter men, women, old and young, and is called an epidemic disease. It is a turbid toxin of warm nature, and warm pathogen and epidemic pathogen are transmitted from mouth and nose, and its etiology is the toxic qi of pestilence. According to clinical cases of traditional Chinese medicine, clinical patients are seen in mild, medium, severe and critical cases. All share the common characteristic of fever, cough, critical period, high fever, asthma, nausea, vomiting and even loose stool, which is basically absent later, and is the manifestation of symptoms. The second symptom is that the symptoms are not obvious at first, the symptoms become severe when the symptoms suddenly change, the patient starts to suffer severe asthma when the patient stands for a hot horse without fever, and most of the patients have thin yellow fur or thin and greasy fur on the tongue. When the critical period is reached, the tongue is yellow and greasy, even yellow and thick greasy, and the true phase is exposed, namely accumulation of phlegm heat and obstruction of qi due to filthy. The affected part and nature of pathogenic factors of the disease can be determined by the contact of patients.
In order to prevent epidemic diseases, new coronary pneumonia and influenza, the application provides a Qingyeyupingfeng powder medicinal beverage which has the advantages of strict formula, golden drug index and mild drug property, can be used for preventing, treating and recovering, and is beneficial to reducing the damage of chemical substances to viscera and lightening sequelae.
Disclosure of Invention
The invention aims to provide a Qingyeyupingfeng powder medicinal beverage and a preparation method thereof, and aims to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme:
the Qingyeyupingfeng powder medicine drink comprises the following raw materials in parts by weight: 12-17 parts of astragalus membranaceus, 9-12 parts of bighead atractylodes rhizome, 8-12 parts of radix sileris, 13-16 parts of folium isatidis, 7-12 parts of scutellaria baicalensis, 8-13 parts of platycodon grandiflorum, 9-13 parts of radix scrophulariae, 8-11 parts of radix ophiopogonis, 13-17 parts of rhizoma phragmitis, 9-12 parts of mint, 8-12 parts of wrinkled gianthyssop herb, 8-12 parts of pericarpium citri reticulatae and 9-12 parts of liquorice.
As a further scheme of the invention: the feed comprises the following raw materials in parts by weight: 15 parts of astragalus mongholicus, 10 parts of bighead atractylodes rhizome, 10 parts of divaricate saposhnikovia root, 15 parts of folium isatidis, 10 parts of baical skullcap root, 10 parts of platycodon grandiflorum, 10 parts of figwort root, 10 parts of dwarf lilyturf tuber, 15 parts of reed rhizome, 10 parts of mint, 10 parts of wrinkled gianthyssop herb, 10 parts of dried orange peel and 10 parts of liquorice.
As a further scheme of the invention: the feed comprises the following raw materials in parts by weight: 12 parts of astragalus mongholicus, 9 parts of bighead atractylodes rhizome, 8 parts of divaricate saposhnikovia root, 13 parts of folium isatidis, 7 parts of baical skullcap root, 8 parts of platycodon grandiflorum, 9 parts of figwort root, 8 parts of dwarf lilyturf tuber, 13 parts of reed rhizome, 9 parts of mint, 8 parts of wrinkled gianthyssop herb, 8 parts of dried orange peel and 9 parts of liquorice.
As a further scheme of the invention: the feed comprises the following raw materials in parts by weight: 17 parts of astragalus mongholicus, 12 parts of bighead atractylodes rhizome, 12 parts of divaricate saposhnikovia root, 16 parts of folium isatidis, 12 parts of baical skullcap root, 13 parts of platycodon grandiflorum, 13 parts of figwort root, 11 parts of dwarf lilyturf tuber, 17 parts of reed rhizome, 12 parts of mint, 12 parts of wrinkled gianthyssop herb, 12 parts of dried orange peel and 12 parts of liquorice.
As a further scheme of the invention: the feed comprises the following raw materials in parts by weight: 16 parts of astragalus mongholicus, 11 parts of bighead atractylodes rhizome, 9 parts of divaricate saposhnikovia root, 14 parts of folium isatidis, 8 parts of baical skullcap root, 12 parts of platycodon grandiflorum, 11 parts of figwort root, 9 parts of dwarf lilyturf tuber, 16 parts of reed rhizome, 11 parts of mint, 10 parts of wrinkled gianthyssop herb, 9 parts of dried orange peel and 11 parts of liquorice.
A preparation method of a Qingyeyupingfeng powder medicinal beverage comprises the following steps:
s1, selecting traditional Chinese medicinal materials of astragalus, bighead atractylodes rhizome, divaricate saposhnikovia root, indigowoad leaf, baical skullcap root, platycodon root, figwort root, dwarf lilyturf tuber, reed rhizome, mint, wrinkled gianthyssop herb, tangerine peel and liquoric root, and drying the traditional Chinese medicinal materials at constant temperature;
s2, crushing the various traditional Chinese medicine materials in the step S1 by traditional Chinese medicine crushing equipment to obtain various traditional Chinese medicine micro rice flour, and weighing and taking out the various traditional Chinese medicine micro rice flour according to the proportion for later use;
s3, extracting half of the traditional Chinese medicine micro rice flour obtained in the step S2 by a traditional Chinese medicine extraction method respectively to obtain various traditional Chinese medicine extract monomers for later use;
s4, mixing the other half of the traditional Chinese medicine micro rice flour obtained in the step S2, soaking the mixture in water for 2-3 hours, decocting the mixture for 3-4 times by using a traditional Chinese medicine decocting device, merging decoction obtained by decocting each time, filtering, and concentrating the obtained filtrate to obtain a traditional Chinese medicine mixed concentrated solution for later use;
s5, mixing the various traditional Chinese medicine extract monomers in the step S3 and the traditional Chinese medicine mixed concentrated solution in the step S4, and preparing the medicine beverage product.
As a further scheme of the invention: the traditional Chinese medicine crushing equipment in the step S2 comprises a low-temperature freezing traditional Chinese medicine crusher and a supersonic airflow crusher, wherein the low-temperature freezing traditional Chinese medicine crusher is used for crushing various traditional Chinese medicine materials to 120-200 meshes, and then the supersonic airflow crusher is used for further crushing to obtain various traditional Chinese medicine micron powder of 1-10 microns.
As a further scheme of the invention: the final form of the pharmaceutical beverage product is: tablet, powder, granule or capsule.
Compared with the prior art, the invention has the beneficial effects that: the healthy qi is strengthened to prevent invasion of exogenous pathogenic factors, the Yupingfeng powder is used for tonifying qi and strengthening exterior in the formula, the astragalus root is sweet, warm and tonifying qi is used for tonifying qi of spleen and lung, the bighead atractylodes rhizome is used for tonifying spleen and removing dampness, dirt turbidity is removed, wind evil is prevented from being dissipated externally, internal qi is raised and yang is cleared, earth is cultivated to prevent transmission and strengthening defense, the bighead atractylodes rhizome, the dried orange peel and the wrinkled gianthyssop are used for tonifying spleen and regulating qi and resolving dampness, the semen is strengthened, heat and toxic materials are removed, the root of Chinese magnoliavine is used for removing the dirt, the lung heat is removed by the reed root and the scutellaria root, the mint is used for dispelling the pathogen by pungent taste, and the platycodon root, the figwort root and the dwarf lilyturf tuber are used for clearing the lung heat, and moistening the lung are used for clearing the heat. The Qingyeyupingfeng powder medicine drink is a prescription for strengthening healthy energy, improving immunity, clearing away the lung-heat and detoxifying, strengthening the spleen and regulating qi and defending evil, and is suitable for all people. The medicinal beverage has clear overall thought, comprehensive consideration, strict formula, golden drug use and mild drug property, and can be used for preventing, treating and recovering, reducing the damage of chemical articles to viscera and lightening sequelae.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1: the Qingyeyupingfeng powder medicine drink specifically comprises the following raw materials in parts by weight: 15 parts of astragalus mongholicus, 10 parts of bighead atractylodes rhizome, 10 parts of divaricate saposhnikovia root, 15 parts of folium isatidis, 10 parts of baical skullcap root, 10 parts of platycodon grandiflorum, 10 parts of figwort root, 10 parts of dwarf lilyturf tuber, 15 parts of reed rhizome, 10 parts of mint, 10 parts of wrinkled gianthyssop herb, 10 parts of dried orange peel and 10 parts of liquorice.
Example 2: the Qingyeyupingfeng powder medicine drink specifically comprises the following raw materials in parts by weight: 12 parts of astragalus mongholicus, 9 parts of bighead atractylodes rhizome, 8 parts of divaricate saposhnikovia root, 13 parts of folium isatidis, 7 parts of baical skullcap root, 8 parts of platycodon grandiflorum, 9 parts of figwort root, 8 parts of dwarf lilyturf tuber, 13 parts of reed rhizome, 9 parts of mint, 8 parts of wrinkled gianthyssop herb, 8 parts of dried orange peel and 9 parts of liquorice.
Example 3: the Qingyeyupingfeng powder medicine drink specifically comprises the following raw materials in parts by weight: 17 parts of astragalus mongholicus, 12 parts of bighead atractylodes rhizome, 12 parts of divaricate saposhnikovia root, 16 parts of folium isatidis, 12 parts of baical skullcap root, 13 parts of platycodon grandiflorum, 13 parts of figwort root, 11 parts of dwarf lilyturf tuber, 17 parts of reed rhizome, 12 parts of mint, 12 parts of wrinkled gianthyssop herb, 12 parts of dried orange peel and 12 parts of liquorice.
Example 4: the Qingyeyupingfeng powder medicine drink specifically comprises the following raw materials in parts by weight: 16 parts of astragalus mongholicus, 11 parts of bighead atractylodes rhizome, 9 parts of divaricate saposhnikovia root, 14 parts of folium isatidis, 8 parts of baical skullcap root, 12 parts of platycodon grandiflorum, 11 parts of figwort root, 9 parts of dwarf lilyturf tuber, 16 parts of reed rhizome, 11 parts of mint, 10 parts of wrinkled gianthyssop herb, 9 parts of dried orange peel and 11 parts of liquorice.
A preparation method of a Qingyeyupingfeng powder medicinal beverage comprises the following steps:
s1, selecting traditional Chinese medicinal materials of astragalus, bighead atractylodes rhizome, divaricate saposhnikovia root, indigowoad leaf, baical skullcap root, platycodon root, figwort root, dwarf lilyturf tuber, reed rhizome, mint, wrinkled gianthyssop herb, tangerine peel and liquoric root, and drying the traditional Chinese medicinal materials at constant temperature;
s2, crushing the various traditional Chinese medicine materials in the step S1 by traditional Chinese medicine crushing equipment to obtain various traditional Chinese medicine micro rice flour, and weighing and taking out the various traditional Chinese medicine micro rice flour according to the proportion for later use;
s3, extracting half of the traditional Chinese medicine micro rice flour obtained in the step S2 by a traditional Chinese medicine extraction method respectively to obtain various traditional Chinese medicine extract monomers for later use;
s4, mixing the other half of the traditional Chinese medicine micro rice flour obtained in the step S2, soaking the mixture in water for 2-3 hours, decocting the mixture for 3-4 times by using a traditional Chinese medicine decocting device, merging decoction obtained by decocting each time, filtering, and concentrating the obtained filtrate to obtain a traditional Chinese medicine mixed concentrated solution for later use;
s5, mixing the various traditional Chinese medicine extract monomers in the step S3 and the traditional Chinese medicine mixed concentrated solution in the step S4, and preparing the medicine beverage product.
The traditional Chinese medicine crushing equipment in the step S2 comprises a low-temperature freezing traditional Chinese medicine crusher and a supersonic airflow crusher, wherein the low-temperature freezing traditional Chinese medicine crusher is used for crushing various traditional Chinese medicine materials to 120-200 meshes, and then the supersonic airflow crusher is used for further crushing to obtain various traditional Chinese medicine micron powder of 1-10 microns. The final form of the pharmaceutical beverage product is: tablet, powder, granule or capsule.
The using method of the invention comprises the following steps: the medicine drink product of 12g is decocted with 150 ml of water each time, and the liquid medicine is taken after being cooled. The specific dosage is as follows: conventional convalescent oral dosage: once in the morning and once in the evening; general prophylactic oral dose: once a day; oral dose for infected persons: once in the morning, at noon and at night. Wherein the dosage of the people with the weight of over 75Kg is 1.5 times of the dosage; the dosage of the people with body weight below 50Kg is 0.5 times of the above dosage.
The medicinal beverage of the invention is prepared from ancient book classic formula of jade screen powder and a formula of leaf mumps. The theory of Huangdi's classic "the theory that the healthy qi exists in the interior, the pathogens cannot be dried" the pathogenic factors are mixed, the qi must be deficient "the pathogens are located, which are all deficient", is the guidance for the formulation of the medicinal beverage of the present invention. The medicinal beverage comprises the following components: the formula has the effects of strengthening healthy qi to prevent invasion of exogenous pathogenic factors, earthing up to generate metal to prevent transmission, strengthening defense, clearing away heat and toxic materials, treating the root cause and clearing the source. Thirteen medicines are ten Chinese published herbal medicines which can be used for homology of medicine and food and used as health care products, and the medicinal drink is safe and reliable to take and has definite efficacy.
The pharmaceutical beverage of the invention is reviewed: the healthy qi is strengthened to prevent invasion of exogenous pathogens, the Yupingfeng powder is used for tonifying qi of the spleen and the lung, the astragalus root is sweet, warm and tonifying qi is used for tonifying qi of the spleen and the lung, the bighead atractylodes rhizome is used for tonifying spleen and removing dampness, dirt is removed, the wind evil is prevented from being dissipated outside the wind, the internal qi is raised and the yang is cleared, the soil is filled and the metal is grown to prevent transmission and transformation, and the defense is strengthened.
The medicinal beverage has clear overall thought, comprehensive consideration, strict formula, golden drug use and mild drug property, and can be used for preventing, treating and recovering, reducing the damage of chemical articles to viscera and lightening sequelae. The medicine beverage of the invention is inspected: the indexes of the detection by the comprehensive detection center of Chinese inspection and quarantine academy of sciences all accord with the 'Chinese pharmacopoeia' 2015 edition.
The drug beverage of the invention is subjected to acute oral toxicity test, and the dosage is set as follows: by adopting a limiting method, the sample amount of the drug beverage of the invention is 1.5g per milliliter of the concentrated solution of the tested object, the concentrated solution of the tested object is used for testing, the intragastric administration volume is 20mL/Kg & BW, and the concentrated solution of the tested object is fully and uniformly mixed before being administered; the test substance is administrated by oral gavage once within 24 hours, and the poisoning expression, the time of appearance and disappearance of symptoms and the death time of animals are observed and recorded immediately after the gavage, and the reduced dose is 30.00g/Kg & BW.
The test method comprises the following steps: 20 healthy mice are selected, each group comprises 10 mice, each of the mice is half male and female, the weight of each mouse is 18-22g, the mice are fasted for 4 hours before the test without water prohibition, and the test objects are marked and weighed on the same day. Animals were observed and recorded immediately after gavage for signs of intoxication, time to appearance and disappearance of symptoms and time to death. The feed was given 2 hours after gavage, observed 0.5, 2, 4 hours after gavage, followed 1 time per day for 14 consecutive days, and the appearance and disappearance of toxic signs and the time of death of the animals were recorded. Gross anatomical examination was performed on all animals and gross pathological changes were recorded for each animal and histopathological observations should be made when gross anatomical pathological changes occurred.
As a result: the test substance was orally administered to female and male ICR mice by gavage at a dose of 30.00g/Kg & BW, and the animals were observed for 14 days after administration of the test substance, and no abnormality was observed in feces, body hair, activity, etc., and no significant abnormality was observed in the change of body weight (Table 1). No signs of toxicity and death associated with the test subjects were noted, and gross anatomy was not abnormal. The results show that the tolerance dose of the test substance to oral acute toxicity of female and male ICR mice is more than 30.00g/Kg & BW, which is practically nontoxic.
TABLE 1 acute toxicity test animal body weight Change (X + -SD)
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Claims (8)
1. The Qingyeyupingfeng powder medicine drink is characterized by comprising the following raw materials in parts by weight: 12-17 parts of astragalus membranaceus, 9-12 parts of bighead atractylodes rhizome, 8-12 parts of radix sileris, 13-16 parts of folium isatidis, 7-12 parts of scutellaria baicalensis, 8-13 parts of platycodon grandiflorum, 9-13 parts of radix scrophulariae, 8-11 parts of radix ophiopogonis, 13-17 parts of rhizoma phragmitis, 9-12 parts of mint, 8-12 parts of wrinkled gianthyssop herb, 8-12 parts of pericarpium citri reticulatae and 9-12 parts of liquorice.
2. The Qingyeyupingfeng powder medicinal beverage as claimed in claim 1, is characterized by comprising the following raw materials in parts by weight: 15 parts of astragalus mongholicus, 10 parts of bighead atractylodes rhizome, 10 parts of divaricate saposhnikovia root, 15 parts of folium isatidis, 10 parts of baical skullcap root, 10 parts of platycodon grandiflorum, 10 parts of figwort root, 10 parts of dwarf lilyturf tuber, 15 parts of reed rhizome, 10 parts of mint, 10 parts of wrinkled gianthyssop herb, 10 parts of dried orange peel and 10 parts of liquorice.
3. The Qingyeyupingfeng powder medicinal beverage as claimed in claim 1, is characterized by comprising the following raw materials in parts by weight: 12 parts of astragalus mongholicus, 9 parts of bighead atractylodes rhizome, 8 parts of divaricate saposhnikovia root, 13 parts of folium isatidis, 7 parts of baical skullcap root, 8 parts of platycodon grandiflorum, 9 parts of figwort root, 8 parts of dwarf lilyturf tuber, 13 parts of reed rhizome, 9 parts of mint, 8 parts of wrinkled gianthyssop herb, 8 parts of dried orange peel and 9 parts of liquorice.
4. The Qingyeyupingfeng powder medicinal beverage as claimed in claim 1, is characterized by comprising the following raw materials in parts by weight: 17 parts of astragalus mongholicus, 12 parts of bighead atractylodes rhizome, 12 parts of divaricate saposhnikovia root, 16 parts of folium isatidis, 12 parts of baical skullcap root, 13 parts of platycodon grandiflorum, 13 parts of figwort root, 11 parts of dwarf lilyturf tuber, 17 parts of reed rhizome, 12 parts of mint, 12 parts of wrinkled gianthyssop herb, 12 parts of dried orange peel and 12 parts of liquorice.
5. The Qingyeyupingfeng powder medicinal beverage as claimed in claim 1, is characterized by comprising the following raw materials in parts by weight: 16 parts of astragalus mongholicus, 11 parts of bighead atractylodes rhizome, 9 parts of divaricate saposhnikovia root, 14 parts of folium isatidis, 8 parts of baical skullcap root, 12 parts of platycodon grandiflorum, 11 parts of figwort root, 9 parts of dwarf lilyturf tuber, 16 parts of reed rhizome, 11 parts of mint, 10 parts of wrinkled gianthyssop herb, 9 parts of dried orange peel and 11 parts of liquorice.
6. A preparation method of a Qingyeyupingfeng powder medicinal beverage is characterized by comprising the following steps:
s1, selecting traditional Chinese medicinal materials of astragalus, bighead atractylodes rhizome, divaricate saposhnikovia root, indigowoad leaf, baical skullcap root, platycodon root, figwort root, dwarf lilyturf tuber, reed rhizome, mint, wrinkled gianthyssop herb, tangerine peel and liquoric root, and drying the traditional Chinese medicinal materials at constant temperature;
s2, crushing the various traditional Chinese medicine materials in the step S1 by traditional Chinese medicine crushing equipment to obtain various traditional Chinese medicine micro rice flour, and weighing and taking out the various traditional Chinese medicine micro rice flour according to the proportion for later use;
s3, extracting half of the traditional Chinese medicine micro rice flour obtained in the step S2 by a traditional Chinese medicine extraction method respectively to obtain various traditional Chinese medicine extract monomers for later use;
s4, mixing the other half of the traditional Chinese medicine micro rice flour obtained in the step S2, soaking the mixture in water for 2-3 hours, decocting the mixture for 3-4 times by using a traditional Chinese medicine decocting device, merging decoction obtained by decocting each time, filtering, and concentrating the obtained filtrate to obtain a traditional Chinese medicine mixed concentrated solution for later use;
s5, mixing the various traditional Chinese medicine extract monomers in the step S3 and the traditional Chinese medicine mixed concentrated solution in the step S4, and preparing the medicine beverage product.
7. The method as claimed in claim 6, wherein the Chinese medicinal pulverization apparatus in step S2 comprises a low-temperature frozen Chinese medicinal pulverizer and a supersonic jet pulverizer, wherein the low-temperature frozen Chinese medicinal pulverizer is used for pulverizing the Chinese medicinal materials into 120-200 meshes, and the supersonic jet pulverizer is used for further pulverizing to obtain 1-10 μm Chinese medicinal micropowder.
8. The method for preparing the Qingyeyupingfeng powder pharmaceutical beverage according to claim 6, wherein the final form of the pharmaceutical beverage product is as follows: tablet, powder, granule, decoction, pill, paste, or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010504711.8A CN111529634A (en) | 2020-06-05 | 2020-06-05 | Qingyeyupingfeng powder medicine beverage and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010504711.8A CN111529634A (en) | 2020-06-05 | 2020-06-05 | Qingyeyupingfeng powder medicine beverage and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111529634A true CN111529634A (en) | 2020-08-14 |
Family
ID=71968983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010504711.8A Pending CN111529634A (en) | 2020-06-05 | 2020-06-05 | Qingyeyupingfeng powder medicine beverage and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111529634A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111991480A (en) * | 2020-09-08 | 2020-11-27 | 钦州市中医医院 | Traditional Chinese medicine composition for preventing novel coronavirus pneumonia infection |
| CN115211479A (en) * | 2022-06-16 | 2022-10-21 | 南方医科大学深圳医院 | Tea drink composition based on edible and medicinal Chinese medicinal materials and application thereof |
| CN115486488A (en) * | 2022-06-16 | 2022-12-20 | 南方医科大学深圳医院 | Tea drink composition for common food and application thereof |
| CN115486487A (en) * | 2022-06-16 | 2022-12-20 | 南方医科大学深圳医院 | Tea drink composition based on medicinal and edible traditional Chinese medicinal materials and application thereof |
| CN115814033A (en) * | 2022-06-27 | 2023-03-21 | 天圣制药集团股份有限公司 | Traditional Chinese medicine composition for preventing, relieving or treating new coronary pneumonia and pharmaceutical application thereof |
-
2020
- 2020-06-05 CN CN202010504711.8A patent/CN111529634A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| 唐晓燕等: "体虚感冒合剂治疗反复上呼吸道感染80 例", 《中医研究》 * |
| 谢春: "《防治感冒的"小食"集锦》", 30 November 2005, 人民军医出版社 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111991480A (en) * | 2020-09-08 | 2020-11-27 | 钦州市中医医院 | Traditional Chinese medicine composition for preventing novel coronavirus pneumonia infection |
| CN115211479A (en) * | 2022-06-16 | 2022-10-21 | 南方医科大学深圳医院 | Tea drink composition based on edible and medicinal Chinese medicinal materials and application thereof |
| CN115486488A (en) * | 2022-06-16 | 2022-12-20 | 南方医科大学深圳医院 | Tea drink composition for common food and application thereof |
| CN115486487A (en) * | 2022-06-16 | 2022-12-20 | 南方医科大学深圳医院 | Tea drink composition based on medicinal and edible traditional Chinese medicinal materials and application thereof |
| CN115814033A (en) * | 2022-06-27 | 2023-03-21 | 天圣制药集团股份有限公司 | Traditional Chinese medicine composition for preventing, relieving or treating new coronary pneumonia and pharmaceutical application thereof |
| CN115814033B (en) * | 2022-06-27 | 2023-09-12 | 天圣制药集团股份有限公司 | Chinese medicinal composition for inhibiting novel coronavirus and pharmaceutical use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111529634A (en) | Qingyeyupingfeng powder medicine beverage and preparation method thereof | |
| CN100408064C (en) | Prepn process of medicine for treating icteric diseases and oral liquid containing the medicine | |
| WO2009117953A1 (en) | Pharmaceutical composition having antidepressive, antianxious action and preparation method thereof | |
| CN111150792A (en) | Chinese medicinal composition with effect of resisting novel coronavirus SARS-Cov-2, and preparation method and application thereof | |
| WO2009117937A1 (en) | A pharmaceutical composition with the effects of hypnosis, anti-depression and anti-anxiety, and preparation thereof | |
| CN105012452A (en) | New application of clausena lansium leaves | |
| CN102380061A (en) | Chinese medicinal composition for eliminating and dissolving phlegm and relieving cough, as well as preparation method and application thereof | |
| CN111317798A (en) | Traditional Chinese medicine composition for detoxifying, eliminating dampness and relieving sore throat and application thereof | |
| CN104189588A (en) | Vitamin C Yinqiao tablets and preparation method thereof | |
| CN105561006B (en) | One kind having treatment alcoholic liver disease function medicament composition and its preparation method and application | |
| CN111202827A (en) | Chinese medicine for preventing influenza, SARS, bird flu and new coronary pneumonia | |
| CN101618146A (en) | Complex traditional Chinese medicine preparation for treating upper respiratory tract infection and preparation method thereof | |
| CN103223069A (en) | Traditional Chinese medicine composition for treating hepatitis | |
| CN101020027B (en) | Medicine composition for preventing and treating AIDS and its preparation process and use | |
| CN103961614A (en) | Traditional Chinese medicine composition for treating respiratory system diseases as well as preparation method and application thereof | |
| CN116785398A (en) | Pharmaceutical composition for preventing qi deficiency damp-heat type viral influenza, preparation and application thereof | |
| CN113476562B (en) | Composition and preparation method and application thereof | |
| CN109316551A (en) | A kind of Chinese medicine composition and preparation method thereof for treating acpuei pharyngitis | |
| CN101390970A (en) | Traditional Chinese medicine for treating hepatitis B and preparation method thereof | |
| CN101543577A (en) | Traditional Chinese medicine composition for curing whelk and preparation method thereof | |
| CN115486488A (en) | Tea drink composition for common food and application thereof | |
| CN104056242A (en) | Traditional Chinese medicine composition for treating acute cholecystitis and preparation method thereof | |
| CN105327115A (en) | Phellinus linteus catharsis formula for prevention and cure of type II diabetes and preparation process thereof | |
| CN104524256A (en) | Traditional Chinese medicine for treating viral pneumonia | |
| CN100446789C (en) | Traditional Chinese medicine pill for clearing toxin of pneumonia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200814 |
|
| RJ01 | Rejection of invention patent application after publication |